BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28722327)

  • 1. Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.
    Santibanez JF; Obradović H; Kukolj T; Krstić J
    Dev Dyn; 2018 Mar; 247(3):382-395. PubMed ID: 28722327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
    Santibanez JF; Krstic J
    Curr Protein Pept Sci; 2018; 19(12):1155-1163. PubMed ID: 29086689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
    Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel patents and cancer therapies for transforming growth factor-beta and urokinase type plasminogen activator: potential use of their interplay in tumorigenesis.
    Krstic J; Maslovaric I; Santibanez JF
    Recent Pat Anticancer Drug Discov; 2014; 9(3):354-71. PubMed ID: 24827562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
    Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
    Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system.
    Ellenrieder V; Hendler SF; Ruhland C; Boeck W; Adler G; Gress TM
    Int J Cancer; 2001 Jul; 93(2):204-11. PubMed ID: 11410867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.
    Santibanez JF
    ISRN Dermatol; 2013; 2013():597927. PubMed ID: 23984088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway.
    Hung WY; Lee WJ; Cheng GZ; Tsai CH; Yang YC; Lai TC; Chen JQ; Chung CL; Chang JH; Chien MH
    Cell Oncol (Dordr); 2021 Oct; 44(5):1087-1103. PubMed ID: 34319576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad4-dependent regulation of urokinase plasminogen activator secretion and RNA stability associated with invasiveness by autocrine and paracrine transforming growth factor-beta.
    Shiou SR; Datta PK; Dhawan P; Law BK; Yingling JM; Dixon DA; Beauchamp RD
    J Biol Chem; 2006 Nov; 281(45):33971-81. PubMed ID: 16959768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase plasminogen activator induces epithelial-mesenchymal and metastasis of pancreatic cancer through plasmin/MMP14/TGF-β axis, which is inhibited by 4-acetyl-antroquinonol B treatment.
    Wu CZ; Chu YC; Lai SW; Hsieh MS; Yadav VK; Fong IH; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen JS
    Phytomedicine; 2022 Jun; 100():154062. PubMed ID: 35366491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta differently regulates urokinase type plasminogen activator and matrix metalloproteinase-9 expression in mouse macrophages; analysis of intracellular signal transduction.
    Mojsilović SS; Santibanez JF
    Cell Biol Int; 2015 May; 39(5):619-28. PubMed ID: 25597879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
    Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
    Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells.
    Festuccia C; Angelucci A; Gravina GL; Villanova I; Teti A; Albini A; Bologna M
    Int J Cancer; 2000 Feb; 85(3):407-15. PubMed ID: 10652434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha(v)beta(3), metalloproteinases, and sphingomyelinase-2 mediate urokinase mitogenic effect.
    Maupas-Schwalm F; Bedel A; Augé N; Grazide MH; Mucher E; Thiers JC; Salvayre R; Nègre-Salvayre A
    Cell Signal; 2009 Dec; 21(12):1925-34. PubMed ID: 19735728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
    Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
    J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
    Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
    BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of urokinase receptor in tumor progression and development.
    Noh H; Hong S; Huang S
    Theranostics; 2013; 3(7):487-95. PubMed ID: 23843896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion.
    Tobar N; Villar V; Santibanez JF
    Mol Cell Biochem; 2010 Jul; 340(1-2):195-202. PubMed ID: 20204677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β regulation of the uPA/uPAR axis modulates mesothelial-mesenchymal transition (MesoMT).
    Logan R; Jeffers A; Qin W; Owens S; Chauhan P; Komatsu S; Ikebe M; Idell S; Tucker TA
    Sci Rep; 2021 Oct; 11(1):21210. PubMed ID: 34707211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.